Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 15;8(3):108-116.
doi: 10.4291/wjgp.v8.i3.108.

Acute and chronic hepatobiliary manifestations of sickle cell disease: A review

Affiliations
Review

Acute and chronic hepatobiliary manifestations of sickle cell disease: A review

Rushikesh Shah et al. World J Gastrointest Pathophysiol. .

Abstract

Sickle cell disease (SCD) is a common hemoglobinopathy which can affect multiple organ systems in the body. Within the digestive tract, the hepatobiliary system is most commonly affected in SCD. The manifestations range from benign hyperbilirubinemia to overt liver failure, with the spectrum of acute clinical presentations often referred to as "sickle cell hepatopathy". This is an umbrella term referring to liver dysfunction and hyperbilirubinemia due to intrahepatic sickling process during SCD crisis leading to ischemia, sequestration and cholestasis. In this review, we detail the pathophysiology, clinical presentation and biochemical features of various acute and chronic hepatobiliary manifestations of SCD and present and evaluate existing evidence with regards to management of this disease process. We also discuss recent advances and controversies such as the role of liver transplantation in sickle cell hepatopathy and highlight important questions in this field which would require further research. Our aim with this review is to help increase the understanding, aid in early diagnosis and improve management of this important disease process.

Keywords: Hepatic sequestration; Hepatobiliary; Hepatopathy; Intrahepatic cholestasis; Iron overload; Liver transplant; Sickle cell cholangiopathy; Sickle cell disease; Sickle cell hepatic crisis.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: This review is contributed by all authors as a voluntary work. Authors have no commercial, financial, political, religious or any other conflicts of interest for contributing to this review.

References

    1. Kolkata: Books and Allied (P) ltd; 2007. Hemoglobin and porphyrin, Textbook of biochemistry. 3rd ed.
    1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38:S512–S521. - PubMed
    1. Ojodu J, Hulihan MM, Pope SN, Grant AM; Centers for Disease Control and Prevention (CDC) Incidence of sickle cell trait--United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63:1155–1158. - PMC - PubMed
    1. Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009;84:323–327. - PubMed
    1. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Temperley WH, Williams TN, Weatherall DJ, Hay SI. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381:142–151. - PMC - PubMed